Cryo-Cell International (CCEL) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Viemed Healthcare (VMD) has outperformed Cryo-Cell International (CCEL) over the past year, gaining 36.4% versus a loss of 11.3%. Over five years, VMD leads with a +62.4% price change compared with -70.3% for CCEL. Viemed Healthcare is the larger company by market cap ($356.9 million vs $31.5 million), about 11.3 times the size.
On valuation, Viemed Healthcare trades at a lower forward P/E (23.4x vs 195.5x for Cryo-Cell International).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCEL | VMD |
|---|---|---|
| Share price | $3.91 | $9.37 |
| Market cap | $31.52M | $356.89M |
| 1-day change | +0.77% | +0.43% |
| YTD return | +13.66% | +26.11% |
| 1-year return | -11.34% | +36.39% |
| 5-year return | -70.27% | +62.39% |
| P/E ratio (TTM) | — | 26.03 |
| Forward P/E | 195.50 | 23.43 |
| EPS (TTM) | $-0.31 | $0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.90 | $12.61 |
| 52-week low | $2.72 | $6.05 |
| Distance from 52-week high | -20.20% | -25.69% |
| Average volume | 23.63K | 354.17K |
| Shares outstanding | 8.06M | 38.09M |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Viemed Healthcare is about 11.3 times larger than Cryo-Cell International by market value ($356.89M vs $31.52M).
- VMD has outperformed CCEL by 47.7 percentage points over the past year.
CCEL vs VMD FAQ
Which is bigger, Cryo-Cell International or Viemed Healthcare?
Viemed Healthcare (VMD) is larger, with a market capitalization of $356.89M compared with $31.52M for Cryo-Cell International (CCEL).
Which stock has performed better over the past year, CCEL or VMD?
VMD returned +36.39% over the past 12 months, compared with -11.34% for CCEL (price return, excluding dividends). Past performance does not predict future results.
Are Cryo-Cell International and Viemed Healthcare in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.